ArticleBMC cancer2025

AHSA1 as a prognostic biomarker and potential immunotherapeutic target in HNSCC: integrative bulk RNA-seq, scRNA-seq analyses and experimental validation.

Feihan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.